2017 Adult Prevalence Tables
| TABLE 8. Estimated percent using inhaled short acting beta agonists among adults1 with current2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2017. | ||||||||
| State/Territory | Current | |||||||
| Sample | % | SE§ | 95% CI† | |||||
| size± | ||||||||
| Arizona | 493 | 53.1 | 3.6 | (46.0 – 60.2) | ||||
| California | 161 | 58.4 | 5.7 | (47.2 – 69.6) | ||||
| Connecticut | 344 | 46.5 | 4.3 | (38.1 – 54.9) | ||||
| Florida | 592 | 54.4 | 4.7 | (45.2 – 63.6) | ||||
| Georgia | 164 | 33.9 | 4.8 | (24.5 – 43.3) | ||||
| Hawaii | 243 | 53.5 | 4.9 | (43.9 – 63.1) | ||||
| Illinois | 163 | 58.8 | 5.2 | (48.6 – 69.0) | ||||
| Indiana | 551 | 54.2 | 3.5 | (47.3 – 61.1) | ||||
| Iowa | 233 | 60.2 | 4.2 | (52.0 – 68.4) | ||||
| Kansas | 494 | 48.9 | 3.2 | (42.6 – 55.2) | ||||
| Kentucky | 336 | 53.1 | 5.1 | (43.1 – 63.1) | ||||
| Maine | 526 | 54.8 | 3.7 | (47.5 – 62.1) | ||||
| Massachusetts | 202 | 55.0 | 6.1 | (43.0 – 67.0) | ||||
| Michigan | 478 | 54.4 | 3.3 | (47.9 – 60.9) | ||||
| Minnesota | 467 | 47.3 | 3.4 | (40.6 – 54.0) | ||||
| Missouri | 214 | 51.8 | 5.6 | (40.8 – 62.8) | ||||
| Montana | 205 | 49.4 | 6.1 | (37.4 – 61.4) | ||||
| Nebraska | 450 | 48.6 | 4.0 | (40.8 – 56.4) | ||||
| Nevada | 128 | 54.8 | 7.3 | (40.5 – 69.1) | ||||
| New Hampshire | 203 | 55.5 | 5.8 | (44.1 – 66.9) | ||||
| New Jersey | 412 | 43.6 | 5.2 | (33.4 – 53.8) | ||||
| New Mexico | 232 | 61.9 | 5.0 | (52.1 – 71.7) | ||||
| New York | 172 | 58.0 | 5.3 | (47.6 – 68.4) | ||||
| Ohio | 363 | 44.8 | 4.4 | (36.2 – 53.4) | ||||
| Oregon | 138 | 58.3 | 5.3 | (47.9 – 68.7) | ||||
| Pennsylvania | 187 | 60.4 | 5.1 | (50.4 – 70.4) | ||||
| Rhode Island | 220 | 53.7 | 4.7 | (44.5 – 62.9) | ||||
| Texas | 339 | 47.9 | 7.0 | (34.2 – 61.6) | ||||
| Utah | 304 | 46.7 | 4.0 | (38.9 – 54.5) | ||||
| Vermont | 250 | 50.3 | 5.3 | (39.9 – 60.7) | ||||
| Wisconsin | 241 | 58.8 | 5.0 | (49.0 – 68.6) | ||||
| Puerto Rico | 146 | 29.7 | 5.4 | (19.1 – 40.3) | ||||
| 32 states / area | 9,651 | 52.9 | 1.3 | (50.4 – 55.4) | ||||
| Median | 53.6 | |||||||
| Range | 29.7-61.9 | |||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2017/pdf/sdq_report_acbs_17-508.pdfpdf icon
Page last reviewed: February 16, 2021